[Osler's disease and congenital cardiopathy (interventricular communication and dilatation of pulmonary artery); efficacy of spiramycin].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D018376:Cardiovascular Abnormalities / Q000150:complications*; D004106:Dilatation; D004696:Endocarditis; D004698:Endocarditis, Subacute Bacterial / Q000150:complications*; D006330:Heart Defects, Congenital; D006801:Humans; D011651:Pulmonary Artery; D015572:Spiramycin; D013683:Telangiectasia, Hereditary Hemorrhagic
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D015572:Spiramycin
ANTIBIOTICS/therapeutic use; CARDIOVASCULAR DEFECTS, CONGENITAL/complications; ENDOCARDITIS, SUBACUTE BACTERIAL/complications
Maladie d'Osler et cardiopathie congénitale (communication interventriculaire et dilatation de l'artère pulmonaire); efficacité de la spiramycine.